Tag : genome sequencing

New technologies will contribute to performing genetic tests to diagnose cancers, rare diseases and other diseases with greater precision, advancing personalized medicine in the country...

Today, Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, proudly announces the launch of Ginkgo Datapoints to usher in the next era...

Industry veteran from Oxford Gene Technology and Invitae Corp with +25 Years of experience to lead expansion of genomic testing offerings and drive innovation in...

Appointment of leading technology innovator supports continued commercial development and R&D expansion Previously Senior Executive at Illumina, Co-Founder and former CEO of Helixis and Luxtera...

Sequentify has partnered with Dexter, a Romanian distributor, to bring Sequentify’s InfiniSeq™ library preparation solutions to Romania. This collaboration offers a cost-effective alternative for next-generation sequencing (NGS)....

Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced the completion of its acquisition of LifeLabs from OMERS. The transaction, valued at approximately CAN $1.35 billion (approximately...

Promotions expand C-suite leadership as company transitions to commercial operation and commences development of large-scale single cell product pipeline. CS Genetics, a privately held genomics...

Internationally-recognized for her work in developing predictive models for drug resistance in cancer treatment University of Maryland School of Medicine (UMSOM) Dean Mark T. Gladwin, MD, announced...

Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced the completion of its acquisition of LifeLabs from OMERS. The transaction, valued at approximately CAN $1.35 billion (approximately...